Co-enzyme Q10 (CoQ10) is a nutritional agent that might play a preventative role in migraine.
A meta-analysis aimed to investigate the effects of CoQ10 as a supplemental agent in migraine.
Web of Science, PubMed and Cochrane Library were searched for potential articles that assessed the effects of CoQ10 on migraine. Data were extracted by two independent reviewers and analyzed with Revman 5.2 software.
Zeng et al. included 5 studies with 346 patients (120 pediatric and 226 adult subjects) in the meta-analysis. CoQ10 was comparable with placebo with respect to migraine attacks/month (P = 0.08) and migraine severity/day (P = 0.08). However, CoQ10 was more effective than placebo in reducing migraine days/month (P <0.00001) and migraine duration (P = 0.009).
This is the first study to demonstrate the effects of CoQ10 supplementation on migraine. The results support the use of CoQ10 as a potent therapeutic agent with respect to migraine duration and migraine days per month. Nonetheless, more studies are needed to support the conclusions 1).
1: Bosch AM, Kamsteeg EJ, Rodenburg RJ, van Deutekom AW, Buis DR, Engelen M, Cobben JM. Coenzyme Q10 deficiency due to a COQ4 gene defect causes childhood-onset spinocerebellar ataxia and stroke-like episodes. Mol Genet Metab Rep. 2018 Sep 13;17:19-21. doi: 10.1016/j.ymgmr.2018.09.002. eCollection 2018 Dec. PubMed PMID: 30225196; PubMed Central PMCID: PMC6138878.
2: Alambyan V, Pace J, Miller B, Cohen ML, Gokhale S, Singh G, Shun MC, Hammond A, Ramos-Estebanez C. The Emerging Role of Inhaled Heroin in the Opioid Epidemic: A Review. JAMA Neurol. 2018 Nov 1;75(11):1423-1434. doi: 10.1001/jamaneurol.2018.1693. PubMed PMID: 29987325.
3: Pehlivanlı F, Aydin O, Karaca G, Aydin G, Devrim T, Bulut H, Bakar B, Daphan ÇE. Healing of Ischemic Colon Anastomosis in Rats Could Be Provided by Administering Dexpanthenol or Coenzyme Q10. J Clin Med. 2018 Jun 25;7(7). pii: E161. doi: 10.3390/jcm7070161. PubMed PMID: 29941836; PubMed Central PMCID: PMC6069384.
4: Da Y, Lei L, Jurkat-Rott K, Lehmann-Horn F. Successful treatment of periodic paralysis with coenzyme Q10: two case reports. Acta Myol. 2016 Oct;35(2):107-108. PubMed PMID: 28344441; PubMed Central PMCID: PMC5343741.
5: Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, Tümer Z, Nielsen JE, Nielsen TT. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017 May;34:103-114. doi: 10.1016/j.mito.2017.03.001. Epub 2017 Mar 3. PubMed PMID: 28263872.
6: Yubero D, Montero R, Martín MA, Montoya J, Ribes A, Grazina M, Trevisson E, Rodriguez-Aguilera JC, Hargreaves IP, Salviati L, Navas P, Artuch R; CoQ deficiency study group, Jou C, Jimenez-Mallebrera C, Nascimento A, Pérez-Dueñas B, Ortez C, Ramos F, Colomer J, O'Callaghan M, Pineda M, García-Cazorla A, Espinós C, Ruiz A, Macaya A, Marcé-Grau A, Garcia-Villoria J, Arias A, Emperador S, Ruiz-Pesini E, Lopez-Gallardo E, Neergheen V, Simões M, Diogo L, Blázquez A, González-Quintana A, Delmiro A, Domínguez-González C, Arenas J, García-Silva MT, Martín E, Quijada P, Hernández-Laín A, Morán M, Rivas Infante E, Ávila Polo R, Paradas Lópe C, Bautista Lorite J, Martínez Fernández EM, Cortés AB, Sánchez-Cuesta A, Cascajo MV, Alcázar M, Brea-Calvo G. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. Mitochondrion. 2016 Sep;30:51-8. doi: 10.1016/j.mito.2016.06.007. Epub 2016 Jun 30. PubMed PMID: 27374853.
7: Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H. Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients. PLoS One. 2016 Feb 19;11(2):e0149557. doi: 10.1371/journal.pone.0149557. eCollection 2016. PubMed PMID: 26894433; PubMed Central PMCID: PMC4760984.
8: Su XW, Nandar W, Neely EB, Simmons Z, Connor JR. Statins accelerate disease progression and shorten survival in SOD1(G93A) mice. Muscle Nerve. 2016 Aug;54(2):284-91. doi: 10.1002/mus.25048. Epub 2016 May 19. PubMed PMID: 26799243; PubMed Central PMCID: PMC5848093.
9: Yubero D, Montero R, Ramos M, Neergheen V, Navas P, Artuch R, Hargreaves I. Determination of urinary coenzyme Q10 by HPLC with electrochemical detection: Reference values for a paediatric population. Biofactors. 2015 Nov-Dec;41(6):424-30. doi: 10.1002/biof.1242. Epub 2015 Nov 19. PubMed PMID: 26768296.
10: Gülşen İ, Ak H, Çölçimen N, Alp HH, Akyol ME, Demir İ, Atalay T, Balahroğlu R, Rağbetli MÇ. Neuroprotective Effects of Thymoquinone on the Hippocampus in a Rat Model of Traumatic Brain Injury. World Neurosurg. 2016 Feb;86:243-9. doi: 10.1016/j.wneu.2015.09.052. Epub 2015 Sep 30. PubMed PMID: 26428323.
11: Kalia LV, Kalia SK, Lang AE. Disease-modifying strategies for Parkinson's disease. Mov Disord. 2015 Sep 15;30(11):1442-50. doi: 10.1002/mds.26354. Epub 2015 Jul 24. Review. PubMed PMID: 26208210.
12: Yubero D, Montero R, Artuch R, Land JM, Heales SJ, Hargreaves IP. Biochemical diagnosis of coenzyme q10 deficiency. Mol Syndromol. 2014 Jul;5(3-4):147-55. doi: 10.1159/000362390. PubMed PMID: 25126047; PubMed Central PMCID: PMC4112526.
13: Baruteau J, Hargreaves I, Krywawych S, Chalasani A, Land JM, Davison JE, Kwok MK, Christov G, Karimova A, Ashworth M, Anderson G, Prunty H, Rahman S, Grünewald S. Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion. 2014 Jul;17:150-6. doi: 10.1016/j.mito.2014.07.001. Epub 2014 Jul 8. PubMed PMID: 25010387.
14: Tarazi FI, Sahli ZT, Wolny M, Mousa SA. Emerging therapies for Parkinson's disease: from bench to bedside. Pharmacol Ther. 2014 Nov;144(2):123-33. doi: 10.1016/j.pharmthera.2014.05.010. Epub 2014 May 20. Review. PubMed PMID: 24854598.
15: Zhang K, Lin JW, Wang J, Wu X, Gao H, Hsieh YC, Hwu P, Liu YR, Su L, Chiou HY, Wang D, Yuan YC, Whang-Peng J, Chiu WT, Yen Y. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis. Genet Med. 2014 Oct;16(10):787-92. doi: 10.1038/gim.2014.39. Epub 2014 Apr 24. PubMed PMID: 24763291; PubMed Central PMCID: PMC4189385.
16: Liu YT, Hersheson J, Plagnol V, Fawcett K, Duberley KE, Preza E, Hargreaves IP, Chalasani A, Laurá M, Wood NW, Reilly MM, Houlden H. Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation. J Neurol Neurosurg Psychiatry. 2014 May;85(5):493-8. doi: 10.1136/jnnp-2013-306483. Epub 2013 Nov 11. PubMed PMID: 24218524; PubMed Central PMCID: PMC3995328.
17: Kalayci M, Unal MM, Gul S, Acikgoz S, Kandemir N, Hanci V, Edebali N, Acikgoz B. Effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats. BMC Neurosci. 2011 Jul 29;12:75. doi: 10.1186/1471-2202-12-75. PubMed PMID: 21801363; PubMed Central PMCID: PMC3160960.
18: Bessero AC, Clarke PG. Neuroprotection for optic nerve disorders. Curr Opin Neurol. 2010 Feb;23(1):10-5. doi: 10.1097/WCO.0b013e3283344461. Review. PubMed PMID: 19915465.
19: Hargreaves IP. Coenzyme Q10 in phenylketonuria and mevalonic aciduria. Mitochondrion. 2007 Jun;7 Suppl:S175-80. Epub 2007 Mar 16. Review. PubMed PMID: 17442628.
20: Land JM, Heales SJ, Duncan AJ, Hargreaves IP. Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. Neurochem Res. 2007 Apr-May;32(4-5):837-43. Epub 2006 Dec 21. Review. PubMed PMID: 17186372.